Investor

Prism VentureWorks

Last cheque observed May 2014. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietGrowth equity

Series CSeries ASeries D

Cheques on record
0%of best year0cheques in 12 months, 14 on record
Since the last cheque4546days00hrs00min00sec
Median round$12MRounds led0 of 14Sole investor2 roundsExits7 from the portfolioMostly inUnited States, 100%
Pitch Prism VentureWorks

Prism VentureWorks highlights

  1. 01

    14 rounds on record

  2. 02

    Mostly Series C and Series A: 54% of its rounds

  3. 03

    Sole investor in 2 rounds, median $4.0M

  4. 04

    7 exits from the portfolio

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Cold pitches
Not stated

The record

Every round we can evidence, newest first14 appearances

  1. 2014

    1 round

  2. May
    Proteon TherapeuticsSeries D · US$45MWith 9 others
  3. 2013

    3 rounds

  4. Dec
    XlumenaSeries C · US · finsmes.com$25MWith 4 others
  5. Nov
    SonianSeries C · US · sec.gov$8.0MWith 2 others
  6. Jun
    Receivables ExchangeGrowth · US · pevc.dowjones.com$10MWith 3 others
  7. 2012

    1 round

  8. Jan
    iScience InterventionalVenture · US · researchviews.com$2.8MWith 5 others
  9. 2008

    1 round

  10. Jan
    ConfirmaSeries C · US$18MWith 3 others
  11. 2007

    8 rounds

  12. Oct
    The New Orleans ExchangeSeries A$4.0MSole investor
  13. Sept
    AtritechSeries D · US$22MWith 5 others
  14. Aug
    MedManage SystemsSeries E · US$5.0MWith 3 others
  15. Jul
    ENTrigue SurgicalSeries A · US$6.3MWith 1 other
  16. Apr
    ReelSeedUndisclosedSole investor
  17. Feb
    Trius TherapeuticsSeries A · US$20MWith 3 others
  18. Feb
    Serica TechnologiesSeries C · US$12MWith 1 other
  19. Feb
    Locus PharmaceuticalsSeries E · US$30MWith 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Exits from the portfolio

Companies it backed that were later bought or listed7 in all

Trius TherapeuticsListedUndisclosedJul 2013
Trius TherapeuticsBought by Cubist Pharmaceuticals$707MJul 2013
ENTrigue SurgicalBought by Arthrocare$45MJul 2013
AtritechBought by Boston Scientific$375MJan 2011
Serica TechnologiesBought by AllerganUndisclosedFeb 2010
ConfirmaBought by Merge HealthcareUndisclosedAug 2009
MedManage SystemsBought by Physicians InteractiveUndisclosedApr 2009

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Prism VentureWorks. A count of rooms they were both in, not a relationship either has claimed.

Versant VenturesVC firm3rounds togetherAffinity Capital ManagementVC firm2rounds together

Quick answers about Prism VentureWorks

What does Prism VentureWorks invest in?

Prism VentureWorks invests most often at Series C and Series A (54% of the rounds on record).

How active is Prism VentureWorks?

14 investments on record, 0 of them in the last 12 months. The most recent was in May 2014.

How big are Prism VentureWorks's cheques?

The median round it joins is $12M.

Does Prism VentureWorks lead rounds?

Rarely, if at all: none of its 14 investments on record names it as the lead.

Where does Prism VentureWorks invest?

Most of the companies it backs are in the United States (100%).

Is Prism VentureWorks investing now?

No investments in the last 12 months; the latest was in May 2014.

Who does Prism VentureWorks invest alongside?

Most often Versant Ventures (3 rounds together) and Affinity Capital Management (2 rounds together).

What kind of investor is Prism VentureWorks?

Prism VentureWorks is a growth equity firm.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it